The RareCyte® platform for next-generation analysis of circulating tumor cells

被引:49
作者
Kaldjian, Eric P. [1 ]
Ramirez, Arturo B. [1 ]
Sun, Yao [1 ]
Campton, Daniel E. [1 ]
Werbin, Jeffrey L. [1 ]
Varshavskaya, Paulina [1 ]
Quarre, Steven [1 ]
George, Tad [1 ]
Madan, Anup [2 ]
Blau, C. Anthony [3 ]
Seubert, Ronald [1 ]
机构
[1] RareCyte Inc, 2601 4th Ave, Seattle, WA 98121 USA
[2] Covance Genom, Redmond, WA USA
[3] Univ Washington, Ctr Canc Innovat, Seattle, WA 98195 USA
关键词
liquid biopsy; circulating tumor cells; cell separation; immunofluorescence microscopy; molecular imaging; image processing; computer assisted; single-cell analysis; DNA amplification techniques; CTC ANALYSIS; PERIPHERAL-BLOOD; LIQUID BIOPSY; SURVIVAL; CANCER;
D O I
10.1002/cyto.a.23619
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Circulating tumor cells (CTCs) can reliably be identified in cancer patients and are associated with clinical outcome. Next-generation "liquid biopsy" technologies will expand CTC diagnostic investigation to include phenotypic characterization and single-cell molecular analysis. We describe here a rare cell analysis platform designed to comprehensively collect and identify CTCs, enable multi-parameter assessment of individual CTCs, and retrieve single cells for molecular analysis. The platform has the following four integrated components: 1) density-based separation of the CTC-containing blood fraction and sample deposition onto microscope slides; 2) automated multiparameter fluorescence staining; 3) image scanning, analysis, and review; and 4) mechanical CTC retrieval. The open platform utilizes six fluorescence channels, of which four channels are used to identify CTC and two channels are available for investigational biomarkers; a prototype assay that allows three investigational biomarker channels has been developed. Single-cell retrieval from fixed slides is compatible with whole genome amplification methods for genomic analysis. (c) 2018 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry.
引用
收藏
页码:1220 / 1225
页数:6
相关论文
共 20 条
[1]   Circulating Tumor Cells: Liquid Biopsy of Cancer [J].
Alix-Panabieres, Catherine ;
Pantel, Klaus .
CLINICAL CHEMISTRY, 2013, 59 (01) :110-118
[2]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[3]   A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer [J].
Blau, C. Anthony ;
Ramirez, Arturo B. ;
Blau, Sibel ;
Pritchard, Colin C. ;
Dorschner, Michael O. ;
Schmechel, Stephen C. ;
Martins, Timothy J. ;
Mahen, Elisabeth M. ;
Burton, Kimberly A. ;
Komashko, Vitalina M. ;
Radenbaugh, Amie J. ;
Dougherty, Katy ;
Thomas, Anju ;
Miller, Christopher P. ;
Annis, James ;
Fromm, Jonathan R. ;
Song, Chaozhong ;
Chang, Elizabeth ;
Howard, Kellie ;
Austin, Sharon ;
Schmidt, Rodney A. ;
Linenberger, Michael L. ;
Becker, Pamela S. ;
Senecal, Francis M. ;
Mecham, Brigham H. ;
Lee, Su-In ;
Madan, Anup ;
Ronen, Roy ;
Dutkowski, Janusz ;
Heimfeld, Shelly ;
Wood, Brent L. ;
Stilwell, Jackie L. ;
Kaldjian, Eric P. ;
Haussler, David ;
Zhu, Jingchun .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (01) :8-17
[4]   Evidence for feasibility of fetal trophoblastic cell-based noninvasive prenatal testing [J].
Breman, Amy M. ;
Chow, Jennifer C. ;
U'Ren, Lance ;
Normand, Elizabeth A. ;
Qdaisat, Sadeem ;
Zhao, Li ;
Henke, David M. ;
Chen, Rui ;
Shaw, Chad A. ;
Jackson, Laird ;
Yang, Yaping ;
Vossaert, Liesbeth ;
Needham, Rachel H. V. ;
Chang, Elizabeth J. ;
Campton, Daniel ;
Werbin, Jeffrey L. ;
Seubert, Ron C. ;
Van den Veyver, Ignatia B. ;
Stilwell, Jackie L. ;
Kaldjian, Eric P. ;
Beaudet, Arthur L. .
PRENATAL DIAGNOSIS, 2016, 36 (11) :1009-1019
[5]   High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining [J].
Campton, Daniel E. ;
Ramirez, Arturo B. ;
Nordberg, Joshua J. ;
Drovetto, Nick ;
Clein, Alisa C. ;
Varshavskaya, Paulina ;
Friemel, Barry H. ;
Quarre, Steve ;
Breman, Amy ;
Dorschner, Michael ;
Blau, Sibel ;
Blau, C. Anthony ;
Sabath, Daniel E. ;
Stilwell, Jackie L. ;
Kaldjian, Eric P. .
BMC CANCER, 2015, 15
[6]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[7]   Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer [J].
de Bono, Johann S. ;
Scher, Howard I. ;
Montgomery, R. Bruce ;
Parker, Christopher ;
Miller, M. Craig ;
Tissing, Henk ;
Doyle, Gerald V. ;
Terstappen, Leon W. W. M. ;
Pienta, Kenneth J. ;
Raghavan, Derek .
CLINICAL CANCER RESEARCH, 2008, 14 (19) :6302-6309
[8]   The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population [J].
Heller, Glenn ;
Fizazi, Karim ;
McCormack, Robert ;
Molina, Arturo ;
MacLean, David ;
Webb, Iain J. ;
Saad, Fred ;
de Bono, Johann S. ;
Scher, Howard I. .
CLINICAL CANCER RESEARCH, 2017, 23 (08) :1967-1973
[9]  
Howard Kellie, 2016, P 107 ANN M AM ASS C, V76
[10]   Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer [J].
Lorente, David ;
Olmos, David ;
Mateo, Joaquin ;
Bianchini, Diletta ;
Seed, George ;
Fleisher, Martin ;
Danila, Daniel C. ;
Flohr, Penny ;
Crespo, Mateus ;
Figueiredo, Ines ;
Miranda, Susana ;
Baeten, Kurt ;
Molina, Arturo ;
Kheoh, Thian ;
McCormack, Robert ;
Terstappen, Leon W. M. M. ;
Scher, Howard I. ;
de Bono, Johann S. .
EUROPEAN UROLOGY, 2016, 70 (06) :985-992